- Home
- HUIZ vs ALLR Comparison
HUIZ vs ALLR Comparison
Compare HUIZ & ALLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUIZ
- ALLR
- Stock Information
- Founded
- HUIZ 2006
- ALLR 2004
- Country
- HUIZ China
- ALLR United States
- Employees
- HUIZ N/A
- ALLR N/A
- Industry
- HUIZ Specialty Insurers
- ALLR Biotechnology: Pharmaceutical Preparations
- Sector
- HUIZ Finance
- ALLR Health Care
- Exchange
- HUIZ Nasdaq
- ALLR Nasdaq
- Market Cap
- HUIZ 18.8M
- ALLR 15.8M
- IPO Year
- HUIZ 2020
- ALLR N/A
- Fundamental
- Price
- HUIZ $2.40
- ALLR $1.01
- Analyst Decision
- HUIZ Hold
- ALLR
- Analyst Count
- HUIZ 1
- ALLR 0
- Target Price
- HUIZ $2.30
- ALLR N/A
- AVG Volume (30 Days)
- HUIZ 18.3K
- ALLR 417.1K
- Earning Date
- HUIZ 06-06-2025
- ALLR 08-04-2025
- Dividend Yield
- HUIZ N/A
- ALLR N/A
- EPS Growth
- HUIZ N/A
- ALLR N/A
- EPS
- HUIZ N/A
- ALLR N/A
- Revenue
- HUIZ $168,454,627.00
- ALLR N/A
- Revenue This Year
- HUIZ $11.94
- ALLR N/A
- Revenue Next Year
- HUIZ $8.15
- ALLR N/A
- P/E Ratio
- HUIZ N/A
- ALLR N/A
- Revenue Growth
- HUIZ 1.28
- ALLR N/A
- 52 Week Low
- HUIZ $1.50
- ALLR $0.61
- 52 Week High
- HUIZ $10.58
- ALLR $7.45
- Technical
- Relative Strength Index (RSI)
- HUIZ 70.21
- ALLR 53.22
- Support Level
- HUIZ $2.11
- ALLR $0.95
- Resistance Level
- HUIZ $2.27
- ALLR $1.08
- Average True Range (ATR)
- HUIZ 0.15
- ALLR 0.07
- MACD
- HUIZ 0.03
- ALLR 0.01
- Stochastic Oscillator
- HUIZ 58.22
- ALLR 59.39
About HUIZ Huize Holding Limited
Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies who cooperate with the company, who the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.